Document is current
Any future updates will be listed below
-
Authors
Volpe, Matthew R. https://orcid.org/0000-0002-0104-2929
Velilla, José A. https://orcid.org/0000-0002-1282-4467
Daniel-Ivad, Martin https://orcid.org/0000-0001-6747-660X
Yao, Jenny J.
Stornetta, Alessia
Villalta, Peter W. https://orcid.org/0000-0002-0067-3083
Huang, Hsin-Che
Bachovchin, Daniel A. https://orcid.org/0000-0001-8210-1662
Balbo, Silvia
Gaudet, Rachelle https://orcid.org/0000-0002-9177-054X
Balskus, Emily P. https://orcid.org/0000-0001-5985-5714
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (F31CA247069, R50CA211256, R01CA208834, R01CA208834)
Howard Hughes Medical Institute
Gouvernement du Canada | Canadian Institutes of Health Research (202012MFE-458776)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM120996)
- License Information
-
More Information
Article History
Received: 8 May 2021
Accepted: 19 August 2022
First Online: 17 October 2022
Competing interests
: E.P.B. and M.R.V. are listed as inventors on a provisional patent (US application 63/135,825) that relates to the methods and compounds described here. The remaining authors declare no competing interests.
